House Approps Approves Bill That Would Give FDA Drug Recall Authority

House Appropriators on Thursday (July 9) passed out of committee an FDA funding bill that would give the agency authority to mandate the recall of unsafe prescription and over-the-counter drugs. The bill, which would give FDA an increase of $40.8 million over fiscal 2020 funding levels for a total of $3.21 billion in discretionary funding, now heads to the House floor. FDA currently can mandate recalls of medical devices and biologic products, such as vaccines and blood products, but can...